Oxidative stress decreases extracellular homocysteine concentration in human hepatoma (HepG2) cell cultures

Chemico-Biological Interactions

Volumn 165, Issue 1, 2007, Pages 54-58

  Hultberg, Malin ^a   Hultberg, Björn ^b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

HeLa cell lines; Hepatoma cell lines; Homocysteine; Hydrogen peroxide; Transsulfuration

Indexed keywords

HOMOCYSTEINE; HYDROGEN PEROXIDE;

AMINO ACID METABOLISM; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HELA CELL; HEPATOMA CELL; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

CARCINOMA, HEPATOCELLULAR; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; EXTRACELLULAR FLUID; HELA CELLS; HOMOCYSTEINE; HUMANS; HYDROGEN PEROXIDE; OXIDATIVE STRESS; SULFUR; TIME FACTORS;

EID: 33845654437     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.10.009     Document Type: Article

References (26)

1. Mudd S.H., Levy H.L., and Skovby F. Disorders of transsulfuration. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Basis of Inherited Disease. seventh ed. (1995), McGraw-Hill Book Co., New York 1279-1327
2. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease. evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1209
3. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a metaanalysis. JAMA 288 (2002) 2015-2022
4. Ueland P.M., and Refsum H. Plasma homocysteine, a risk factor for vascular disease: modulation by pharmacological intervention and pathological states. J. Lab. Clin. Med. 114 (1989) 473-501
5. Refsum H., Guttormsen A.B., Fiskerstrand T., and Ueland P.M. On the formation and fate of total plasma homocysteine. In: Graham I., Refsum H., Rosenberg I.H., and Ueland P.M. (Eds). Homocysteine Metabolism: From Basic Science to Clinical Medicine (1997), Kluwer Academic Publication, Boston 23-30
6. Hultberg B., Andersson A., and Isaksson A. Higher export rate of homocysteine in a human endothelial cell line than in other human cell lines. Biochim. Biophys. Acta 1448 (1998) 61-69
7. Hultberg B. Extracellular concentration of homocysteine in human cell lines is influenced by specific inhibitors of cyst(e)ine transport. Clin. Chem. Lab. Med. 42 (2004) 378-383
8. Hultberg B. Modulation of extracellular homocysteine concentration in human cell lines. Clin. Chim. Acta 330 (2003) 151-159
9. Hultberg B., Andersson A., and Isaksson A. The effects of homocysteine and copper ions on the concentration and redox status of thiols in cell line cultures. Clin. Chim. Acta 262 (1997) 39-51
10. Hultberg B., Andersson A., and Isaksson A. Thiol redox status influences extracellular concentration of homocysteine in HeLa cell cultures. Clin. Chem. Lab. Med. 38 (2000) 1243-1247
11. Hultberg B. Elimination of high amounts of extracellular homocysteine in human cell lines. Clin. Chim. Acta 356 (2005) 117-124
12. Mosharov E., Cranford M.R., and Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 39 (2000) 13005-13011
13. Banerjee R., and Zou C.-gang. Redox regulation and reaction mechanism of human cystathioine-β-synthase: a PLP-dependent hemesensor protein. Arch. Biochem. Biophys. 433 (2005) 144-156
14. Hultberg B., Andersson A., and Isaksson A. Thiol and redox reactive agents exert different effects on glutathione metabolism in HeLa cell cultures. Clin. Chim. Acta 283 (1999) 21-32
15. Hultberg B., Andersson A., and Isaksson A. Copper ions differ from other thiol reactive metal ions in their effects on the concentration and redox status of thiols in HeLa cell cultures. Toxicology 117 (1997) 89-97
16. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
17. Persa C., Pierce A., Ma Z., Kabil O., and Lou M.F. The presence of a transsulfuration pathway in the lens: a new oxidative stress defense system. Exp. Eye Res. 79 (2004) 875-886
18. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 98 (1996) 5-7
19. Chen N., Liu Y., Greiner C.D., and Holzman J.L. Physiological concentrations of homocysteine inhibits the human plasma GSH peroxidase that reduces organic hydroperoxides. J. Lab. Clin. Med. 136 (2000) 58-65
20. Moat S.J., Hill M.H., McDowell I.F., Pullin C.H., Ashfield-Watt P.A., Clark Z.E., Whiting J.M., Newcombe R.G., Lewis M.J., and Powers H.J. Reduction in plasma total homocysteine through increasing folate intake in healthy individuals is not associated with changes in measures of antioxidant activity or oxidant damage. Eur. J. Clin. Nutr. 57 (2003) 483-489
21. Huerta J.M., Gonzalez S., Fernandez S., Patterson A.M., and Lasheras C. No evidence for oxidative stress as a mechanism of action of hyperhomocysteinemia in humans. Free Rad. Res. 38 (2004) 1215-1221
22. Finkelstein J.D. Pathways and regulation of homocysteine metabolism in mammals. Sem. Thromb. Hemost. 26 (2000) 219-225
23. Toole J.F., Malinow M.R., Chambless L.E., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 291 (2004) 565-575
24. Bonaa K.H., et al., The NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 354 (2006) 1578-1588
25. The Hearth Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B Vitamins in vascular disease. N. Engl. J. Med. 354 (2006) 1567-1577
26. Loscalzo J. Homocysteine trials-clear outcomes for complex reasons. N. Engl. J. Med. 354 (2006) 1629-1632